NASDAQ:NMRA | Cash Flow Statement | Neumora Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$43.08M
2026-03-31-$53.46M$8,000.00-$46.4M$71,000.00$10.88M
2025-12-31-$59.45M$9,000.00-$47.96M$42.65M$58.77M
2025-09-30-$56.76M
2025-06-30-$52.73M
2025-03-31-$67.99M$157,000.00-$59.45M$44.16M$0.00
2024-12-31-$58.82M$157,000.00-$50.34M-$98.8M$15.57M
2024-09-30-$72.55M
2024-06-30-$58.7M
2024-03-31-$53.72M$158,000.00-$42.96M-$150M$1.85M
2023-12-31-$108.73M$166,000.00-$51.44M$44,000.00$13.68M-$481,000.00
2023-09-30-$53.03M
2023-06-30-$38.54M
2023-03-31-$35.63M$158,000.00-$33.04M$36,000.00$2.82M$101,000.00
2022-12-31-$28.15M$147,000.00-$30.37M$23,000.00-$8.03M$26.83M
2022-09-30-$29.34M
2022-06-30-$30.37M
2022-03-31-$43.04M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$236.93M$208,000.00-$206.44M$168.52M$77.09M
2024-12-31-$243.79M$631,000.00-$182.94M-$70.56M$21.6M
2023-12-31-$235.93M$668,000.00-$163.28M$117,000.00$64.39M$231.94M
2022-12-31-$130.9M$594,000.00-$114.9M$511,000.00-$168.01M$115.74M